NCT07619651 Comparison of Sacral Erector Spinae Block and Caudal Epidural Block for Postoperative Analgesia in Pediatric Hypospadias Surgery
| NCT ID | NCT07619651 |
| Status | Recruiting |
| Phase | — |
| Sponsor | TC Erciyes University |
| Condition | Hypospadias |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2026-01-05 |
| Primary Completion | 2026-09-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2026-01-05 with a primary completion date of 2026-09-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Hypospadias surgery in pediatric patients requires effective postoperative analgesia to ensure patient comfort and reduce perioperative stress. Caudal epidural block is widely used for analgesia in pediatric urological procedures; however, alternative regional techniques such as the sacral erector spinae plane (ESP) block have recently gained attention. This prospective comparative study aims to compare the analgesic efficacy of sacral ESP block and caudal epidural block in pediatric patients undergoing hypospadias surgery. Participants will be allocated to receive either sacral ESP block or caudal epidural block according to the study protocol. The primary outcome will be postoperative pain scores within the first 24 hours after surgery. Secondary outcomes will include total analgesic consumption, time to first rescue analgesia, and block-related complications.
Eligibility Criteria
Inclusion Criteria: 1. Male patients aged between 6 months to 7 years 2. Scheduled for hypospadias repair surgery 3. ASA physical status I-II 4. No known allergy to local anesthetic agents 5. No contraindications to peripheral nerve blocks 6. Written informed consent obtained from parents or legal guardians Exclusion Criteria: 1. Known congenital coagulopathy 2. Known allergy to local anesthetic agents 3. Severe systemic disease (ASA III-IV) 4. Severe organ failure 5. Neurological disorders
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07619651 clinical trial?
This trial is open to male participants only, aged 6 Months or older, up to 7 Years, studying Hypospadias. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07619651 currently recruiting?
Yes, NCT07619651 is actively recruiting participants. Contact the research team at oozgergin@erciyes.edu.tr for enrollment information.
Where is the NCT07619651 trial being conducted?
This trial is being conducted at Kayseri, Turkey (Türkiye).
Who is sponsoring the NCT07619651 clinical trial?
NCT07619651 is sponsored by TC Erciyes University. The trial plans to enroll 60 participants.